Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-01-18-Speech-2-436-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2011-01-18"^^xsd:date2
dcterms:Is Part Of	lp_eu:Patients’ rights in cross-border healthcare (debate)2
dcterms:Language	"nl"^^xsd:language2
lpv:document identification number	"en.20110118.19.2-436-000"2
lpv:hasSubsequent	lp_eu:2011-01-18-Speech-2-437-0002
lpv:speaker	lp:Kartika Tamara Liotard2
lpv:spokenAs	unknown; Onafhankelijk lid (2010-06-01--2014-06-30)3 substitute; FEMM (2009-07-16--2012-01-18)3 substitute; DEVE (2009-07-16--2012-01-18)3 member; Delegation for relations with Japan (2009-09-16--2014-06-30)3 member; ENVI (2009-07-16--2012-01-18)3 vice-chair; EUL/NGL (2009-07-14--2012-02-06)3
lpv:translated text	"Mr President, tomorrow is the big day when healthcare becomes an internal market product. The new directive treats healthcare as a piece of commercially tradeable goods. Those who have the most money will be the first to access the places with the largest and cheapest supply of care. This proposal, however, will maintain the existing two-tier healthcare system. I wonder how many of my fellow Members can identify with what I’m saying. Healthcare is a basic need and one to which everyone should have equal access. Those of you who are going to vote in favour tomorrow are probably thinking that you will be striking a blow for patients, but that will most definitely not be the case. I am in favour of anything that advances the rights of patients, but if we adopt this directive, we can actually expect numerous problems in the area of patient rights; I will give you a few examples. Insurers will be only too happy to send patients across the border if there is a cheaper treatment option there. That will decrease the supply of care in the patients’ countries of origin. Any treatments that are no longer profitable will no longer be offered in the more expensive regions. Far from giving them more rights, that will leave patients with no choice and they will to travel across the border. Besides, patients from regions where care is cheaper will not be able to travel to other regions, as they will not automatically be compensated for the additional costs which that will entail. Health tourism, which is the intended objective of this directive, will, therefore, be restricted to just the rich. Turning now to regions where healthcare is cheap and to those where waiting times are short. Eventually, they will have many health tourists coming in that their own local patients will be squeezed out. We were able to read an example of this in Monday’s edition of the Belgian and I can assure you that more such examples will follow. I believe that every patient has the right to quality care and care which is provided in their own language, close to where they live, with their family close at hand. Instead of that, Europe is encouraging patients to seek care abroad and then letting the market do its work. Those of you who agree with that will vote in favour tomorrow; those of you who agree with me should definitely vote against."@en1
lpv:unclassifiedMetadata	"De Standaard"1 "have"1 "so"1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph